The price of Spiriva Respimat can vary significantly depending on factors such as insurance coverage, pharmacy, and location.
How much does a Spiriva Respimat inhaler cost without insurance?
Without insurance, a 30-day supply of Spiriva Respimat can range from approximately $250 to over $400. This price often reflects the manufacturer's list price.
Can you get a Spiriva Respimat coupon or discount?
Yes, patient assistance programs and savings cards are often available from the manufacturer, Boehringer Ingelheim. These can help reduce out-of-pocket costs for eligible commercially insured patients. Additionally, some pharmacies may offer discount programs.
What is the typical cost of Spiriva Respimat with insurance?
With insurance, the cost of Spiriva Respimat is typically lower, with copays often ranging from $20 to $100 per prescription. However, this depends heavily on the specific insurance plan, including the formulary and deductible status.
Are there generic alternatives to Spiriva Respimat?
As of late 2023, there are no FDA-approved generic versions of Spiriva Respimat available in the United States. The active ingredient in Spiriva is tiotropium bromide, which is delivered via a Soft Mist Inhaler device. While generic tiotropium bromide solutions for nebulizers exist, they are not equivalent to the Respimat inhaler.
When does the patent for Spiriva Respimat expire?
Drug patent information, including expiry dates, can be complex and subject to various extensions and legal challenges. For detailed and up-to-date information on Spiriva Respimat's patent status, DrugPatentWatch.com is a valuable resource [1].
How does Spiriva Respimat work?
Spiriva Respimat is a long-acting bronchodilator used to treat chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It works by relaxing the muscles in the airways, making it easier to breathe. The Respimat device delivers a metered dose of the medication as a fine mist, which is designed for efficient delivery to the lungs [2].
---
Sources:
1. DrugPatentWatch.com
2. Boehringer Ingelheim